(Q53460878)

14 May 2018

title

Quality of life and symptoms in a randomized trial of radiotherapy versus deferred treatment of localized prostate carcinoma. (English)

1 reference

14 May 2018

adaptive radiation therapy

main subject

0 references

author name string

Fransson P

1

1 reference

14 May 2018

Damber JE

2

1 reference

14 May 2018

Tomic R

3

1 reference

14 May 2018

Modig H

4

1 reference

14 May 2018

Nyberg G

5

1 reference

14 May 2018

Widmark A

6

1 reference

14 May 2018

language of work or name

English

0 references

publication date

1 December 2001

1 reference

14 May 2018

published in

Cancer

1 reference

14 May 2018

volume

92

1 reference

14 May 2018

issue

12

1 reference

14 May 2018

page(s)

3111-3119

1 reference

14 May 2018

Late effects of radiation therapy for prostate carcinoma: the patient's perspective of bladder, bowel and sexual morbidity.

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011215%2992%3A12%3C3111%3A%3AAID-CNCR10160%3E3.0.CO%3B2-E

Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011215%2992%3A12%3C3111%3A%3AAID-CNCR10160%3E3.0.CO%3B2-E

Quality-of-life outcomes in men treated for localized prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011215%2992%3A12%3C3111%3A%3AAID-CNCR10160%3E3.0.CO%3B2-E

Measurement of quality of life in localized prostatic cancer patients treated with radiotherapy. Development of a prostate cancer-specific module supplementing the EORTC QLQ-C30.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011215%2992%3A12%3C3111%3A%3AAID-CNCR10160%3E3.0.CO%3B2-E

Long-term morbidity and quality of life in patients with localized prostate cancer undergoing definitive radiotherapy or radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011215%2992%3A12%3C3111%3A%3AAID-CNCR10160%3E3.0.CO%3B2-E

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011215%2992%3A12%3C3111%3A%3AAID-CNCR10160%3E3.0.CO%3B2-E

Quality of life and treatment outcomes: prostate carcinoma patients' perspectives after prostatectomy or radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011215%2992%3A12%3C3111%3A%3AAID-CNCR10160%3E3.0.CO%3B2-E

Quality of life in patients with prostatic cancer: results from a Swedish population study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011215%2992%3A12%3C3111%3A%3AAID-CNCR10160%3E3.0.CO%3B2-E

The EORTC core quality of life questionnaire (QLQ-C30): validity and reliability when analysed with patients treated with palliative radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011215%2992%3A12%3C3111%3A%3AAID-CNCR10160%3E3.0.CO%3B2-E

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011215%2992%3A12%3C3111%3A%3AAID-CNCR10160%3E3.0.CO%3B2-E

Psychometric validation of the EORTC Core Quality of Life Questionnaire, 30-item version and a diagnosis-specific module for head and neck cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011215%2992%3A12%3C3111%3A%3AAID-CNCR10160%3E3.0.CO%3B2-E

Test/retest study of the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011215%2992%3A12%3C3111%3A%3AAID-CNCR10160%3E3.0.CO%3B2-E

Psychometric properties and responsiveness of the EORTC quality of Life Questionnaire (QLQ-C30) in patients with breast, ovarian and lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011215%2992%3A12%3C3111%3A%3AAID-CNCR10160%3E3.0.CO%3B2-E

The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011215%2992%3A12%3C3111%3A%3AAID-CNCR10160%3E3.0.CO%3B2-E

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011215%2992%3A12%3C3111%3A%3AAID-CNCR10160%3E3.0.CO%3B2-E

Effect of pelvic radiotherapy for prostate cancer on bowel, bladder, and sexual function: the patient's perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011215%2992%3A12%3C3111%3A%3AAID-CNCR10160%3E3.0.CO%3B2-E

Daily-diary evaluated side-effects of conformal versus conventional prostatic cancer radiotherapy technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011215%2992%3A12%3C3111%3A%3AAID-CNCR10160%3E3.0.CO%3B2-E

Underreporting by cancer patients: the case of response-shift.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011215%2992%3A12%3C3111%3A%3AAID-CNCR10160%3E3.0.CO%3B2-E

Psychosocial status in chronic illness. A comparative analysis of six diagnostic groups.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011215%2992%3A12%3C3111%3A%3AAID-CNCR10160%3E3.0.CO%3B2-E

Natural history of localised prostatic cancer. A population-based study in 223 untreated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011215%2992%3A12%3C3111%3A%3AAID-CNCR10160%3E3.0.CO%3B2-E

Recent results of management of palpable clinically localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011215%2992%3A12%3C3111%3A%3AAID-CNCR10160%3E3.0.CO%3B2-E

Population-based study of long-term survival in patients with clinically localised prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011215%2992%3A12%3C3111%3A%3AAID-CNCR10160%3E3.0.CO%3B2-E

10.1002/1097-0142(20011215)92:12<3111::AID-CNCR10160>3.0.CO;2-E

21 January 2018

Identifiers

DOI

1 reference

14 May 2018

1 reference

14 May 2018